Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prithviraj Bose

Showing results (71-80 of 224) with videos related to

Pageof 23
Sort By:
Core Evidence|January 23, 2015
Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapyJennifer Dinnel, Bonny L Moore, Brent M Skiver, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2021
SOHO State of the Art Updates and Next Questions: Novel Therapies in Development for MyelofibrosisHelen T Chifotides, Prithviraj Bose, Lucia Masarova, et al.
Rheumatology (Oxford, England)|September 21, 2014
Remission of rheumatoid arthritis on brentuximab vedotinPankit Vachhani, Nilanjana Bose, James P Brodeur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2018
Breakthrough Fungal Infections in Patients With Leukemia Receiving IsavuconazoleCaitlin R Rausch, Adam J DiPippo, Prithviraj Bose, et al.
Journal of Clinical Microbiology|January 29, 2011
Disseminated fusariosis occurring in two patients despite posaconazole prophylaxisPrithviraj Bose, Hiral D Parekh, Jennifer L Holter, et al.
Acta Haematologica|April 21, 2021
Accelerated Phase of Myeloproliferative NeoplasmsOmar A Shahin, Helen T Chifotides, Prithviraj Bose, et al.
Leukemia Research|March 22, 2017
Haptoglobin is frequently low in patients with myelofibrosis: Clinical relevancePaolo Strati, Lucia Masarova, Prithviraj Bose, et al.
Leukemia Research|April 6, 2017
The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based reviewPrajwal Boddu, Lorenzo Falchi, Chitra Hosing, et al.
Leukemia & Lymphoma|April 21, 2023
Ten years after ruxolitinib approval for myelofibrosis: a review of clinical efficacyNaveen Pemmaraju, Prithviraj Bose, Raajit Rampal, et al.
Clinical Case Reports|January 30, 2018
Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposureAhmad Alhuraiji, Kiran Naqvi, Yang O Huh, et al.
Pageof 23

Showing results (71-80 of 224) with videos related to

Sort By:
Pageof 23
Core Evidence|January 23, 2015
Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapyJennifer Dinnel, Bonny L Moore, Brent M Skiver, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2021
SOHO State of the Art Updates and Next Questions: Novel Therapies in Development for MyelofibrosisHelen T Chifotides, Prithviraj Bose, Lucia Masarova, et al.
Rheumatology (Oxford, England)|September 21, 2014
Remission of rheumatoid arthritis on brentuximab vedotinPankit Vachhani, Nilanjana Bose, James P Brodeur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2018
Breakthrough Fungal Infections in Patients With Leukemia Receiving IsavuconazoleCaitlin R Rausch, Adam J DiPippo, Prithviraj Bose, et al.
Journal of Clinical Microbiology|January 29, 2011
Disseminated fusariosis occurring in two patients despite posaconazole prophylaxisPrithviraj Bose, Hiral D Parekh, Jennifer L Holter, et al.
Acta Haematologica|April 21, 2021
Accelerated Phase of Myeloproliferative NeoplasmsOmar A Shahin, Helen T Chifotides, Prithviraj Bose, et al.
Leukemia Research|March 22, 2017
Haptoglobin is frequently low in patients with myelofibrosis: Clinical relevancePaolo Strati, Lucia Masarova, Prithviraj Bose, et al.
Leukemia Research|April 6, 2017
The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based reviewPrajwal Boddu, Lorenzo Falchi, Chitra Hosing, et al.
Leukemia & Lymphoma|April 21, 2023
Ten years after ruxolitinib approval for myelofibrosis: a review of clinical efficacyNaveen Pemmaraju, Prithviraj Bose, Raajit Rampal, et al.
Clinical Case Reports|January 30, 2018
Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposureAhmad Alhuraiji, Kiran Naqvi, Yang O Huh, et al.
Pageof 23